Repligen Corporation, a life sciences company focused on bioprocessing technology leadership, today announced it has entered into a strategic partnership and exclusive license agreement with DRS ...
Data make up a crucial element in Bioprocessing 4.0. Biomanufacturers must efficiently collect, manage, and analyze this information. Compatibility between devices, data sources, and software packages ...
Companies are scrambling right now to respond to a rapidly changing context, and they’re using data to navigate the necessary transformations. But too often, they’ve failed to make needed changes ...
ABBYY is meeting the $5.3 billion market demand for purpose-built AI to deliver process optimization1 by offering two new Process AI solutions: Process AI for Consulting (PAIC) and IDP Analytics. The ...
Celonis has today announced the acquisition of Process Analytics Factory GmbH (PAF), a company that specializes in providing process mining insights within the Microsoft Power Platform. The deal will ...
Celonis, the process mapping startup, has been on a nice run the last several years, forging significant partnerships with IBM and ServiceNow, while announcing a $1 billion Series D last June on a ...
Tribble, a generative artificial intelligence company that helps automate the tedious request-for-proposal process for sales and security teams, today announced the launch of a new analytics ...
Lucas M. Schroth and Urszula Jessen founded Process.Science to address inefficiencies in traditional data analysis. The company utilizes an AI-powered process mining platform that integrates ...
One challenge for the business process movement has always been the tradeoff between deep analysis and improvement-oriented actions. Process analysis—understanding and measuring a process and the ...
German data process mining software firm Celonis GmbH made a key acquisition today, buying a rival in the market called Process Analytics Factory GmbH for an undisclosed fee. Celonis said the ...
The starting material for virtually all pharmaceuticals and biologics is a synthetic or chemical. Human plasma-derived therapies are one of the few exceptions. A number of fragile proteins can be ...